Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers.
about
Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis.Topical Naltrexone as Treatment for Type 2 Diabetic Cutaneous WoundsMapping of genetic abnormalities of primary tumours from metastatic CRC by high-resolution SNP arrays.Association between genetic subgroups of pancreatic ductal adenocarcinoma defined by high density 500 K SNP-arrays and tumor histopathologyOpioids, Neutral Endopeptidase, its Inhibitors and Cancer: Is There a Relationship among them?Comparison of stimulating effect on subpopulations of lymphocytes in human peripheral blood by methionine enkephalin with IL-2 and IFN-γ.Internalization of the opioid growth factor, [Met5]-enkephalin, is dependent on clathrin-mediated endocytosis for downregulation of cell proliferationOpioid growth factor and the treatment of human pancreatic cancer: a review.Opioid system and Alzheimer's disease.Serum [Met(5)]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone.Inhibition of the growth of human melanoma cells by methionine enkephalin.Opioid growth factor - opioid growth factor receptor axis inhibits proliferation of triple negative breast cancer.Macrophage polarization induced by neuropeptide methionine enkephalin (MENK) promotes tumoricidal responses.Under-expression of the opioid growth factor receptor promotes progression of human ovarian cancer.Low-dose naltrexone targets the opioid growth factor-opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model.Low-dose naltrexone suppresses ovarian cancer and exhibits enhanced inhibition in combination with cisplatin.Opioid growth factor (OGF) for hepatoblastoma: a novel non-toxic treatment.High Level of Fasting Plasma Proenkephalin-A Predicts Deterioration of Kidney Function and Incidence of CKD.Methionine enkephalin (MENK) improves lymphocyte subpopulations in human peripheral blood of 50 cancer patients by inhibiting regulatory T cells (Tregs).Featured Article: Nuclear export of opioid growth factor receptor is CRM1 dependentIntegrated proteomic and transcriptomic analysis revealslong noncoding RNA HOTAIR promotes hepatocellular carcinoma cell proliferation by regulating opioid growth factor receptor (OGFr).Selective blockade of the OGF-OGFr pathway by naltrexone accelerates fibroblast proliferation and wound healing.Targeted overexpression of OGFr in epithelium of transgenic mice suppresses cell proliferation and impairs full-thickness wound closure.Novel treatment for triple-negative breast and ovarian cancer: endogenous opioid suppression of women's cancers.Modulation of the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: novel therapies for squamous cell carcinoma of the head and neck.Killing effect of methionine enkephalin on melanoma in vivo and in vitro.Topical Naltrexone Is a Safe and Effective Alternative to Standard Treatment of Diabetic Wounds.The novel mechanism of anticancer effect on gastric cancer through inducing G0/G1 cell cycle arrest and caspase-dependent apoptosis in vitro and in vivo by methionine enkephalin
P2860
Q33511045-88A30515-CED9-4EFC-99D8-E6951C5B69CEQ33724491-B29F0812-D9A8-437B-9F8D-694597612CB6Q33741891-400C1186-E6F2-4C31-BAEE-732537448139Q33979834-CD062766-A933-4C30-ACC4-B403AAAC960AQ35598669-87A4FD1E-3E6D-4C95-8D46-940861ECA07CQ36552894-F0E09DAA-AF87-4DBC-99B5-181D58EB9D68Q37174499-0BDEDC3D-24AA-4179-BB19-E6F31682E442Q37617951-879D3C27-2448-4D0A-A06E-7BE53A495739Q38004941-928FCF1E-98BB-4B9C-817E-F0DD4503EBEEQ38647159-4EDBA029-9849-44BD-8D44-5B1DF3BE5BB9Q38729547-CDD91543-C574-4C02-AE40-56F6068797EEQ39114818-4C5ED098-5C3C-426A-835E-54D95EB7A1B8Q39379509-CAA8A6C2-66CA-4A19-9F43-1E79E0C58050Q39397468-770CA31F-E361-4F06-9E31-8B2B6A84044BQ39496812-84A63141-2616-4C1D-8B1A-505635883D6AQ39522079-19A34136-EF32-42D0-AB44-25BD63A1D5AEQ40262668-451C3618-F223-4402-AB98-61A55943CC58Q40656900-F879137E-437E-4D8E-AC44-189EE7E52AE2Q41807400-9CCE694F-1F6B-41E5-A545-91A37BD2FBD2Q41848369-F7DA0308-0856-4204-8085-3D244BAAA94CQ42778320-82CAF569-18FB-4FA2-B680-9D3AC10AF43AQ42799555-E647B66F-1285-4A7B-ABE0-F65914559DDFQ44031670-FE268535-5B7B-474F-86A5-F52F38E3C8EBQ44342789-CC852DCB-3969-43BB-80A3-8C92F7874A12Q44350786-5C54D556-9D12-4F77-99EE-93198E493471Q47143232-2EEA0074-1F55-495C-A8AC-AF6D2E5B48C2Q50144166-C2C24C87-8A53-44AA-8F6C-3B388347DF13Q58694707-5738AA33-6EA5-4A39-B58C-605FEAAFFC11
P2860
Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Opioid growth factor-opioid gr ...... tion in diverse human cancers.
@en
Opioid growth factor-opioid gr ...... tion in diverse human cancers.
@nl
type
label
Opioid growth factor-opioid gr ...... tion in diverse human cancers.
@en
Opioid growth factor-opioid gr ...... tion in diverse human cancers.
@nl
prefLabel
Opioid growth factor-opioid gr ...... tion in diverse human cancers.
@en
Opioid growth factor-opioid gr ...... tion in diverse human cancers.
@nl
P2093
P2860
P1476
Opioid growth factor-opioid gr ...... tion in diverse human cancers.
@en
P2093
Ian S Zagon
Patricia J McLaughlin
Renee N Donahue
P2860
P304
P356
10.1152/AJPREGU.00414.2009
P577
2009-08-12T00:00:00Z